The economic burden of diagnostic pathways: An analysis of patients costs at the Rapid Access Diagnostic Lymph Adenopathy Clinic (RADLAC) at Groote Schuur Hospital in Cape Town, South Africa

Thesis / Dissertation

2026

Permanent link to this Item
Authors
Journal Title
Link to Journal
Journal ISSN
Volume Title
Publisher
Publisher

University of Cape Town

License
Series
Abstract
Globally, cancer is one of the leading causes of mortality and morbidity, with the greatest burden in low- and middle-income countries where approximately 65% -70% of deaths occur. Cancer is the non-communicable disease most likely to lead to catastrophic health expenditure. This can occur at any phase along the continuum of cancer care. There exists a gap in the literature on expenditures incurred prior to receiving a diagnosis. Delays in receiving a diagnosis may lead to adverse health outcomes along the cancer care continuum; moreover, in some cases, these delays can cause financial distress for the individual and household. The Rapid Access Diagnostic LymphAdenopathy Clinic (RADLAC) was established to enable rapid diagnosis of patients with lymphadenopathy. The opening of this clinic provided a chance to understand the types, magnitude, and drivers of cancer-related costs for patients seeking a diagnosis as well as their households. The aim of this study was to analyse patient costs associated with seeking a diagnosis at the RADLAC at Groote Schuur Hospital, a tertiary academic hospital in Cape Town, South Africa. The objectives of the study were to calculate the direct and indirect costs related to diagnosis for patients attending the RADLAC. The study also measured the intangible dimension of pain. Coping strategies used by patients to cover costs were also investigated. The study was a cross-sectional patient cost analysis. Data were collected from consenting newly referred and previously referred adult patients. A structured questionnaire collecting direct (medical and non-medical) and indirect costs was used to collect data via in-person interviews. Pain was measured using the Brief Pain Inventory (BPI), which has been validated for South African use, to capture the intangible dimension associated with lymphadenopathy (LAP). Data was collected in REDCap and analysed using Stata18. Patient costs were calculated up to the point of diagnosis. We found that patients incurred significant direct costs prior to attending the clinic, with out-of-pocket (OOP) payments spent on general practitioners and transport costs making up the majority of these expenses. For some individuals, monthly transport costs to RADLAC accounted for 15% of their monthly expenditure. Patients also lost earnings whilst seeking a diagnosis with 29% reporting lost earnings from attending the RADLAC. Most patients had informal caregivers who lost a significant proportion of their daily wages each time they had to accompany the patient to seek health care services. Of the patients who had someone accompany them to the clinic, 44% of them reported lost earnings on that day Patients coped with the costs of health care using a multitude of strategies. Almost 80% of low-income households reduced spending on other household categories to pay for health care costs. It was observed that many individuals also borrowed from informal lenders who charged interest rates as high as 50%. Pain caused by lymphadenopathy was a common symptom reported by patients. Most patients reported that the pain due to lymphadenopathy and/or its accompanying symptoms interfered with their daily functioning. In addition, pain also affected their sleep and their enjoyment of life. In some cases, patients had to incur additional direct medical costs to manage lymphadenopathy-associated pain, i.e., additional trips to the pharmacy for pain medication. South Africa has pledged to achieve Universal Health Coverage (UHC) through the implementation of the National Health Insurance (NHI). Comprehensive financial risk protection is critical to achieving UHC and relates to the pursuit of Sustainable Development Goal 3. Direct and indirect costs of seeking a diagnosis influence health-seeking behaviours and influence health outcomes. Despite care being free at the point of service at primary health care facilities in South Africa, patients incur substantial direct non-medical costs in the form of transport costs. Indirect costs in the form of foregone wages are also incurred each time care is sought, and these losses account for a significant proportion of patients' monthly income. Further costs may be incurred when accessing secondary or tertiary facilities rather than primary health facilities. Comprehensive health, social, and economic policies are needed to ensure that patients are adequately protected from the costs of illness, particularly the costs associated with cancer diagnosis and care.
Description

Reference:

Collections